Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TSEC for Metabolic Dysfunction in Postmenopausal Women
NCT02274571Phase 1Completed
- Sponsor
- Pennington Biomedical Research Center
- Start
- Sep 2015
- Primary completion
- Apr 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in metabolic dysfunction comparing TSEC (Duavee) with Placebo (2 arms). Primary endpoints: Effect of CE/BZA (TSEC) on Body Composition at 8 weeks, Effect of CE/BZA (TSEC) on Ectopic Fat at 8 weeks and 4 more. Started Sep 2015; status: completed.
02
Drugs
bazedoxifene
03
Conditions
metabolic dysfunction
Beyond the preview
Go deeper on NCT02274571.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02274571.